HORIZON 2020 (2014-2020). Call: Health SC1-DTH-05-2019
FUNDING BODY: European Commission.
An ageing population is increasing demand-side pressures on public health and social care providers across Europe. These pressures undermine the long-term sustainability of existing models for delivering care services to the ageing population. The challenge is to scale up outcome-based innovative digital health and care solutions across EU borders through joining up actions in procurement of innovation
- At least three legal entities. Each of the three must be established in a different EU Member State or Horizon 2020 associated country. All three legal entities must be independent of each other.
- Furthermore, there must be a minimum of two legal entities which are ‘public procurers’ from two different EU Member States or Horizon 2020 associated countries. Both legal entities must be independent of each other.
SC1-DTH-05-2019-2020: Large scale implementation of digital innovation for health and care in an ageing society.
Scope: This topic will contribute to the Digital Single Market Strategy priorities on digital transformation of health and care (notably to the priority on user-centred integrated care), to the Scaling-Up Strategy134 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) and will support the EIP on AHA Reference Sites contribution to the Digital Single Market Strategy, notably the priority focusing on user-centred integrated care. The actions supported will target large-scale deployment of digital health and care solutions across different regions in Europe. In line with the priority actions of the EIP on AHA Scaling-up Strategy, the scope of this PPI is to specify, purchase and deploy ICT based solutions (made up of services and ICT products to enable the provision of services) for active and healthy ageing through a common supply and demand side dialogue, which can deliver sustainable, new or improved health and care services promoting patient feedback in which public procurement approaches for innovative solutions lead to improved outcomes.
- Established path to innovation, evidence of benefits of disruptive technologies that can support the development of sustainable business models, improved user and market engagement, strengthened procurement community, evidence of healthy innovation ecosystem including researchers, users, eHealth and other solution providers and procurers. Evidence in key performance areas i.e., quality in health and care, sustainability of the delivery system and economic value.
- Increased opportunities for solution uptake across wider international procurement markets by aiming at interoperable solutions that are validated through field testing by participating procurers in multiple countries across Europe and contribution to standardisation where relevant.
Indicative request from the EU: between €2-5M
Type of Action: Public Procurement of Innovative solutions PPI
INSTRUMENT FUNDING LEVEL
The funding rate for Public Procurement of Innovative solutions PPI actions is limited to 35% of the total eligible costs to leverage co-financing from the procurers.
- Personnel cost.
- Other direct cost: travel and subsistence; equipment, informatics, consumables.
- Indirect cost (25% total direct cost, except subcontracting).
- Information on the outcome of the evaluation: Maximum 5 months from the final date for submission.
- Indicative date for the signing of grant agreements: Maximum 8 months from the final date for submission.
INDICATIVE BUDGET: Total budget € million 10.00